Pfizer's (PFE) short interest as a percent of float has fallen 9.0% since its last report. According to exchange reported data, there are now 103.47 million shares sold short, which is 1.82% of all ...

A few years ago, Pfizer (NYSE: PFE) saw revenue soar to record heights thanks to coronavirus-related sales, from its vaccine ...

In remarks in Providence, Rhode Island, Powell noted that there are risks to both of the Fed’s goals of seeking maximum ...

Thank you all for being here this afternoon.I thank our hosts Macquarie, a great Australian success story.Among many distinguished guests, I ...

Wachtell guides Pfizer as it scrambles to win a slice in booming obesity drug market with Paul Weiss-repped Metsera ...

The journey toward an RSV vaccine for children has been wrought with tragedy and setbacks. But six decades after scientists embarked on that path, they are nearing the finish line ...

American Indian and Alaska Native infants experience the highest rates of RSV-related hospitalization in the U.S., but a ...

Pfizer is paying $47.50 a share in cash for Metsera, a 43% premium on the startup’s closing price on Friday that gives the ...

The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how the markets will ...

Pfizer is doubling down on obesity treatments by spending 4.9 billion US dollars (£3.6 billion) on the development-stage drugmaker Metsera. The Covid-19 vaccine and treatment maker said on Monday that ...

The U.S. twice earlier this month carried out fatal strikes against alleged drug-smuggling vessels that had originated from ...

Separately, the ACIP members reversed their vote on a recommendation they’d shot down Thursday pertaining to coverage of ...